Antengene Alternatives & Competitors
12 companies similar to Antengene — Treating Patients Beyond Borders.
Companies similar to Antengene
Prescient Therapeutics
A clinical stage oncology company developing personalised medicine approaches to cancer; c...
Australia
MEI Pharma
Committed to the development of novel, best-in-class, cancer therapies intended to provide...
San Diego, United States
Lisata Therapeutics, Inc.
Targeted Therapy Delivered
United States
ALX Oncology
ALX Oncology is a clinical-stage biotechnology company advancing cancer therapies by boost...
South San Francisco, Unit...
Track all Antengene competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
DEM Biopharma, Inc.
Novel Target for Solid Tumors
Cambridge, United States
Soricimed Biopharma Inc.
Dedicated to developing effective and novel targeted treatments for cancer.
Canada
Kiromic Biopharma, Inc.
Cell therapy company with end-to-end bioinformatic, AI targeting, and manufacturing techno...
Houston, United States
Cytovation
Creating transformative medicines for patients with cancer
Bergen, Norway
Sensei Bio
We follow the immune system’s teachings to discover new treatments that inspire the body t...
Rockville, United States
Kinnate Biopharma Inc.
Inspiring Hope to Those Battling Cancer
San Diego, United States
Elevation Oncology
We are focused on discovering and developing selective cancer therapies to treat patients...
Boston, United States
Takeda Oncology
We aspire to cure cancer, with inspiration from patients and innovation from everywhere.
Cambridge, United States
About Antengene
Antengene Corporation Limited is a biopharmaceutical company established in 2016 with the vision of "Treating Patients Beyond Borders." The company is dedicated to the discovery, development, manufacturing, and commercialization of innovative therapeutics for hematologic malignancies and solid tumors. Antengene has a p...
Biopharmaceuticals, Oncology Research, Global Commercialization, Clinical Programs, Tumor Treatment, Drug Development, Hematologic Malignancies, Solid Tumors, Asia Pacific Market, Drug Manufacturing, Medical Research, Patient-centric Approach, Innovation In Cancer Therapies, Market Authorizations, Commercial-stage Biotech
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Antengene and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Antengene on 12 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 22 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
